The Assessment of Infrared Treatment for Crohn's Disease

Who May Qualify: 1. An established Crohn's disease 2. 18 \< age \< 80 3. No therapy or on constant medicinal regimen throughout the study period: mesalamine at least 6 weeks, or steroids at least 2 weeks, or immunomodulatory drugs at least 12 weeks or biologics at least 12 weeks, medical cannabis at least 2 weeks before the study. 4. CD patients will be included if their symptoms score \>4 on the Harvey-Bradshaw index (HBI) score and/or fecal calprotectin level \> 150 ug/gr. Who Should NOT Join This Trial: 1. BMI greater than 30 Kg/m2 2. Any proven current infection such as Clostridioides difficile infection, positive stool culture, or parasites. 3. Inability to sign willing to sign a consent form and complete study protocol 4. Pregnancy 5. Subjects with chronic conditions such as cancer, organ transplant subjects, advanced kidney or liver disease, systemic inflammatory conditions other than IBD. 6. Presence of abscess and cysts in the liver/ kidneys or pancreas 7. Evidence of an abdominal abscess or entero-enteric fistula. 8. More than one CD luminal surgery or a small bowel length \< 1.5 meter Always talk to your doctor about whether this trial is right for you.